Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ · Healthcare
Orchestra BioMed Holdings, Inc. Total Liabilities 2022–2025
Orchestra BioMed Holdings, Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Orchestra BioMed Holdings, Inc. total liabilities for the quarter ending December 31, 2025 were 51.5M, a 19.12% increase year-over-year.
- Orchestra BioMed Holdings, Inc. total liabilities for 2025 were 51.5M, a 19.12% increase from 2024.
- Orchestra BioMed Holdings, Inc. total liabilities for 2024 were 43.2M, a 59.06% increase from 2023.
- Orchestra BioMed Holdings, Inc. total liabilities for 2023 were 27.2M, a 36.87% decrease from 2022.
- Orchestra BioMed Holdings, Inc. total liabilities for 2022 were 43.0M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Orchestra BioMed Holdings, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $51 |
| 2024 | $43 |
| 2023 | $27 |
| 2022 | $43 |
| Orchestra BioMed Holdings, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $51 |
| 2024-12-31 | $43 |
| 2023-12-31 | $27 |
| 2022-12-31 | $43 |
Orchestra BioMed Holdings, Inc. Total Liabilities — FAQ
Orchestra BioMed Holdings, Inc. (OBIO) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see OBIO's total liabilities history?
The chart and table above show Orchestra BioMed Holdings, Inc.'s total liabilities by year and by quarter, including the growth rate.